Enhanced radiosensitization of tumor cells by means of the combined exposure of hyperthermia and proteasome inhibitors

«Radiation and Risk», 2020, vol. 29, No. 4, pp.118-125

DOI: 10.21870/0131-3878-2020-29-4-118-125

Authors

Kabakov A.E. – Head of Lab., C. Sc., Biol. Contacts: 4 Korolyov str., Obninsk, Kaluga region, Russia, 249035. Tel.: +7 (484) 399-71-88; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
Mosina V.A. – Researcher
Khokhlova A.V. – Researcher. A. Tsyb MRRC.

A. Tsyb MRRC, Obninsk

Abstract

Hyperthermia is used in combination with radiation therapy to enhance the radiation response of the target tumor. However, many tumors are thermoresistant, which makes the thermo-radiosensitization ineffective. In this work, we studied a possibility of enhancing the radiosensitizing effect of hyperthermia on cancer cells in the case of combining heating and treatments with inhibitors of proteasomal protein degradation. The objects of the study were HeLa, MCF-7, and PC-3 cell lines derived from human carcinomas of various localization. Before irradiation (2-6 Gy), cell cultures were subjected to heat stress (42-44 °C for 20-60 min) without or in the presence of proteasome inhibitors (MG132, bortezomib). The death and survival of the treated cells was evaluated by the level of apoptosis/necrosis, by clonogenicity, and in the MTT test. The proteotoxicity of the exposures and the subcellular redistribution of heat shock proteins were analyzed using cell fractionation, electrophoresis, and immunoblotting. The results show that, compared with hyperthermia, the combined effect (hyperthermia + proteasome inhibitor) significantly increased the radiosensitization of cancer cells, which was manifested in the intensification of their postradiation death and significant suppression of clonogenicity. Thus, the combination of hyperthermia with proteasome inhibitors (for example, with bortezomib, which is clinically approved) can help sensitize radioresistant tumors to radiation therapy.

Key words
tumor radioresistance, radiation response, heat stress, proteotoxicity, gama-radiation, heat shock proteins, chaperones, protein degradation, cancer cells, velcade, radiation therapy.

References

1. Datta N.R., Ordonez S.G., Gaipl U.S., Paulides M.M., Crezee H., Gellermann J., Marder D., Puric E., Bod-is S. Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and prom-ises for the future. Cancer Treat. Rev., 2015, vol. 41, no. 9, pp. 742-753.

2. Hyperthermic oncology from bench to bedside. Eds.: S. Kokura, T. Yoshikawa, T. Ohnishi. Springer, 2016. 444 p.

3. Peeken J.C., Vaupel P., Combs S.E. Integrating hyperthermia into modern radiation oncology: what evidence is necessary? Front. Oncol., 2017, vol. 7, article132, pp. 1-17. DOI: 10.3389/fonc.2017.00132.

4. Kabakov A.E., Anokhin Yu.N., Lebedeva T.V. Reactions of normal and tumor cells and tissues to hyperthermia in combination with ionizing radiation. Review. Radiatsija i risk – Radiation and Risk, 2018, vol. 27, no. 4, pp. 141-154. (In Russian).

5. Kabakov A.E., Kudryavtsev V.A., Khokhlova A.V., Makarova Yu.M., Lebedeva T.V. Apoptosis in tumor cells subjected to the combined action of hyperthermia and irradiation: a study of the molecular mecha-nisms and targets. Radiatsija i risk – Radiation and risk, 2018, vol. 27, no. 2, pp. 62-75. (In Russian).

6. Thibaudeau T.A., Smith D.M. A practical review of proteasome pharmacology. Pharmacol. Rev., 2019, vol, 71, no. 2, pp. 170-197.

7. Kabakov A.E., Gabai V.L. Cell death and survival assays. Methods Mol. Biol., 2018, vol. 1709, pp. 107-127.

8. Kudryavtsev V.A., Makarova Yu.M., Kabakov A.E. Thermosensitization of tumor cells with inhibitors of chaperone activity and expression. Biomeditsinskaya khimiya – Biomedical Chemistry, 2012, vol. 58, no. 6, pp. 662-672. (In Russian).

9. Cengiz Seval G., Beksac M. The safety of bortezomib for the treatment of multiple myeloma. Expert Opin. Drug Saf., 2018, vol. 17, no. 9, pp. 953-962.

10. Rybinski M., Szymanska Z., Lasota S., Gambin A. Modelling the efficacy of hyperthermia treatment. J. R. Soc. Interface, 2013, vol. 10, no. 88, pp. 20130527. DOI: 10.1098/rsif.2013.0527.

Full-text article (in Russian)